Trial
NCT05050162
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
NRG Oncology
Collaborators
National Cancer Institute (NCI)
Condition
Advanced Head and Neck Squamous Cell Carcinoma
Intervention
Cisplatin
Why stopped
End of Initial Phase of Multi-phase protocol; closed for protocol specified analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-25